X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (184) 184
metallurgy (184) 184
organic chemistry (159) 159
peptides (159) 159
human necessities (141) 141
hygiene (141) 141
medical or veterinary science (141) 141
preparations for medical, dental, or toilet purposes (141) 141
microbiology (132) 132
beer (131) 131
biochemistry (131) 131
enzymology (131) 131
mutation or genetic engineering (131) 131
spirits (131) 131
vinegar (131) 131
wine (131) 131
compositions or test papers therefor (81) 81
condition-responsive control in microbiological orenzymological processes (81) 81
measuring or testing processes involving enzymes, nucleicacids or microorganisms (81) 81
processes of preparing such compositions (81) 81
specific therapeutic activity of chemical compounds ormedicinal preparations (79) 79
index medicus (72) 72
physics (65) 65
compositions thereof (64) 64
culture media (64) 64
microorganisms or enzymes (64) 64
propagating, preserving or maintaining microorganisms (64) 64
animals (46) 46
humans (46) 46
mice (43) 43
investigating or analysing materials by determining theirchemical or physical properties (41) 41
measuring (41) 41
testing (41) 41
immunology (39) 39
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (35) 35
general tagging of cross-sectional technologies spanning over several sections of the ipc (25) 25
general tagging of new technological developments (25) 25
technical subjects covered by former uspc (25) 25
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (25) 25
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (25) 25
information and communication technology [ict] specially adaptedfor specific application fields (24) 24
female (20) 20
gene expression (20) 20
mice, inbred c57bl (20) 20
derivatives thereof (18) 18
nucleic acids (18) 18
nucleosides (18) 18
nucleotides (18) 18
sugars (18) 18
abridged index medicus (17) 17
mice, knockout (17) 17
cells, cultured (16) 16
inflammation (14) 14
medicine, research & experimental (14) 14
cytokine (13) 13
dendritic cells (13) 13
lymphocytes (13) 13
t cells (13) 13
combinatorial chemistry (12) 12
expression (12) 12
libraries, e.g. chemical libraries, in silicolibraries (12) 12
male (12) 12
oncology (12) 12
t-cells (12) 12
cytokines (11) 11
interleukins (11) 11
molecular sequence data (11) 11
amino acid sequence (10) 10
article (10) 10
healthcare informatics, i.e. information and communicationtechnology [ict] specially adapted for the handling orprocessing of medical or healthcare data (10) 10
il-23 (10) 10
inflammation - immunology (10) 10
ligands (10) 10
research (10) 10
autoimmune inflammation (9) 9
cancer (9) 9
ifn-gamma (9) 9
immunohistochemistry (9) 9
interleukin-17 - biosynthesis (9) 9
interleukins - physiology (9) 9
middle aged (9) 9
receptor (9) 9
aged (8) 8
central-nervous-system (8) 8
disease models, animal (8) 8
t-lymphocytes - immunology (8) 8
adult (7) 7
base sequence (7) 7
differentiation (7) 7
flow cytometry (7) 7
il-12 (7) 7
immunotherapy (7) 7
induction (7) 7
interleukin-23 (7) 7
interleukin-23 - immunology (7) 7
interleukin-23 subunit p19 (7) 7
lymphocytes t (7) 7
mice, inbred balb c (7) 7
t-lymphocytes, helper-inducer - immunology (7) 7
tgf-beta (7) 7
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (293) 293
French (58) 58
German (26) 26
Chinese (7) 7
Spanish (7) 7
Portuguese (6) 6
Danish (1) 1
Greek (1) 1
Korean (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Immunity, ISSN 1074-7613, 10/2015, Volume 43, Issue 4, pp. 727 - 738
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2017, Volume 127, Issue 8, pp. 2930 - 2940
Programmed death-1-directed (PD-1-directed) immune checkpoint blockade results in durable antitumor activity in many advanced malignancies. Recent studies... 
CELL LUNG-CANCER | MEDICINE, RESEARCH & EXPERIMENTAL | MELANOMA | PEMBROLIZUMAB | LIGANDS | IMMUNOTHERAPY | SAFETY | TOLERANCE | ADAPTIVE IMMUNE RESISTANCE | EXPRESSION | Immunohistochemistry | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Interferon-gamma - metabolism | Immune System | Carcinoma - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Signal Transduction | Skin Neoplasms - immunology | Carcinoma - immunology | Programmed Cell Death 1 Receptor - metabolism | Treatment Outcome | Stomach Neoplasms - drug therapy | Stomach Neoplasms - immunology | Carcinoma, Non-Small-Cell Lung - immunology | B7-H1 Antigen - metabolism | Lung Neoplasms - immunology | Pilot Projects | Sequence Analysis, RNA | Biopsy | Melanoma - immunology | Melanoma - drug therapy | ROC Curve | Carcinoma, Non-Small-Cell Lung - drug therapy | PD-1 protein | Lung cancer | Clinical trials | Cytotoxicity | Biology | Lymphocytes T | Cancer therapies | Metastases | Lymphocytes | Neck | Adaptation | Antigen presentation | Squamous cell carcinoma | Cytokines | Melanoma | Inflammation | Gene expression | Immune checkpoint | PD-L1 protein | Head and neck cancer | Antitumor activity | Ligands | Interferon | Chemokines | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 12, pp. 3158 - 3167
Journal Article
Science, ISSN 0036-8075, 10/2018, Volume 362, Issue 6411, pp. 197 - 197
Programmed cell death protein-1 (PD-1) and programmed cell death ligand-1 (PD-L1) checkpoint blockade immunotherapy elicits durable antitumor effects in... 
CELL LUNG-CANCER | MISMATCH-REPAIR DEFICIENCY | MUTATIONAL PROCESSES | METASTATIC MELANOMA | CTLA-4 BLOCKADE | MULTIDISCIPLINARY SCIENCES | COPY NUMBER | PROGRAMMED DEATH LIGAND-1 | SEQUENCING DATA | CLINICAL-RESPONSE | SOMATIC MUTATIONS | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Transcriptome | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Genetic Markers | Cell Cycle Checkpoints | Neoplasms - therapy | Neoplasms - genetics | Antineoplastic Agents, Immunological - therapeutic use | Immunotherapy | Inflammation - genetics | T-Lymphocytes - immunology | Tumor Burden - genetics | Biomarkers, Tumor - genetics | Mutation | Molecular Targeted Therapy - methods | Monoclonal antibodies | Genetic aspects | T cells | Biological markers | Gene expression | Cancer | Tumors | Apoptosis | Cell receptors | Physiological aspects | Diagnosis | Identification and classification | Methods | PD-1 protein | Clinical trials | Genomes | Biology | Lymphocytes T | Microsatellite instability | Data bases | Subgroups | Anticancer properties | Proteins | Cell activation | Pembrolizumab | Databases | Antigenicity | Lymphocytes | Bioindicators | Deoxyribonucleic acid--DNA | Medical research | Stability | Microsatellites | Mortality | Melanoma | Data processing | Inflammation | Patients | Immune checkpoint | Cell death | Correlation analysis | PD-L1 protein | Biomarkers | Ligands | Antitumor activity | Cutoffs | Solid tumors | Index Medicus
Journal Article
Journal Article
Nature, ISSN 0028-0836, 05/2015, Volume 521, Issue 7551, pp. 222 - 226
Journal Article